Aspiriant, LLC Astrazeneca PLC Transaction History

Aspiriant, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$48.52 - $58.02 $179,524 - $214,674	-3,700 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $196,359 - $226,070	3,700 New	3,700 $203,000
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $259,124 - $277,875	-7,500 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$32.97 - $36.63 $247,275 - $274,725	7,500 New	7,500 $262,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.